Product description

Cardiovascular diseases and dyslipidemias, and alteration of gut microbiota are connected: people with high cholesterol levels have often an altered gut microbiota, qualitatively and quantitatively.  Probiotics are reported to be able to reduce bloody fat levels, acting with different mechanism of action.Phytosterols are well known and widely used to reduce cholesterol levels.
Folic acid is involved on metabolism of homocysteine, alteration of which is related to an increased cardiovascular risk.
On these basis Cerbios developed its innovative Food supplement, with:
- SF68 (proprietary probiotic strain)
- phytosterols
- Methylfolate (biological active form of folic acid)
Scientific evidences: preclinical test demonstrates significant reduction of obesity and fat levels.
A clinical trial is on going to demonstrate efficacy on reduce: cholesterol, obesity and fat. 

Read more

Specifications

Categories Probiotics
Sales markets Western Europe; Eastern Europe; Middle East; Asia; North America; Central/South America
Supplied from Switzerland
Product Applications Food Supplements; Pharmaceutical
Product Certifications Health & Safety (GMP, HAACP and equivalents); Health claims

Products from other suppliers